Alzheimer Disease Clinical Trials in Columbus, Ohio

4 studies are recruiting for alzheimer disease in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.

    Stage
    Phase 2
    Ages
    55 to 90
    Site
    Local Institution - 0087, Columbus, Ohio
    Locations
    78 in total
    Run by
    Celgene

    See if you can join NCT06808984 on ClinicalTrials.gov

  2. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

    Stage
    Phase 3
    Ages
    55 to 90
    Site
    Ohio State University, Columbus, Ohio
    Locations
    293 in total
    Run by
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company

    See if you can join NCT06585787 on ClinicalTrials.gov

  3. Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

    The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults with mild cognitive impairment (MCI) or mild Alzheimer's Disease and related dementias (ADRD) and their care partners. The…

    Stage
    Not phased
    Ages
    60 and older
    Site
    The Ohio State University, Columbus, Ohio
    Locations
    3 in total
    Run by
    Florida State University

    See if you can join NCT05748613 on ClinicalTrials.gov

  4. ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

    The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

    Stage
    Not phased
    Ages
    50 to 85
    Site
    The Ohio State University -Wexner Medical Center, Columbus, Ohio
    Locations
    10 in total
    Run by
    InSightec

    See if you can join NCT03671889 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.